AnaptysBio Inc’s recent filing unveils that its CEO Faga Daniel unloaded Company’s shares for reported $64268.0 on Mar 25 ’24. In the deal valued at $21.42 per share,3,000 shares were sold. As a result of this transaction, Faga Daniel now holds 749,087 shares worth roughly $15.99 million.
Then, Faga Daniel sold 145,940 shares, generating $3,325,185 in total proceeds. Upon selling the shares at $22.78, the CEO now owns 752,087 shares.
Before that, LOUMEAU ERIC J sold 5,000 shares. AnaptysBio Inc shares valued at $125,000 were divested by the CHIEF LEGAL OFFICER at a price of $25.00 per share. As a result of the transaction, LOUMEAU ERIC J now holds 3,240 shares, worth roughly $69141.6.
Leerink Partners initiated its AnaptysBio Inc [ANAB] rating to an Outperform in a research note published on April 16, 2024; the price target was $47. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in mid April with a ‘”an Overweight”‘ rating. Wedbush also remained covering ANAB and has increased its forecast on March 12, 2024 with a “an Outperform” recommendation from previously “Neutral” rating. BTIG Research started covering the stock on February 26, 2024. It rated ANAB as “a Buy”.
Price Performance Review of ANAB
On Tuesday, AnaptysBio Inc [NASDAQ:ANAB] saw its stock jump 0.33% to $21.34. Over the last five days, the stock has lost -0.88%. AnaptysBio Inc shares have fallen nearly -0.37% since the year began. Nevertheless, the stocks have fallen -0.88% over the past one year. While a 52-week high of $27.50 was reached on 02/26/24, a 52-week low of $13.36 was recorded on 04/03/24. SMA at 50 days reached $23.45, while 200 days put it at $20.07. A total of 0.24 million shares were traded, compared to the trading of 0.27 million shares in the previous session.
Levels Of Support And Resistance For ANAB Stock
The 24-hour chart illustrates a support level at 20.86, which if violated will result in even more drops to 20.39. On the upside, there is a resistance level at 21.98. A further resistance level may holdings at 22.63. The Relative Strength Index (RSI) on the 14-day chart is 45.05, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.09, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 79.11%. Stochastics %K at 28.90% indicates the stock is a holding.
The most recent change occurred on February 21, 2024 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
